Boston University School of Medicine Study Finds Vitamin D May Help Patients Fight COVID-19 Infections, But Some Question These Conclusions

Oct 28, 2020 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing, Management & Operations, News From Dark Daily

Clinical laboratory managers may want to follow the debate that surfaced shortly after publication of the study in a peer-reviewed journal, when editors of the journal issued concerns over the researchers’ claims Virologists and medical laboratory scientists continue to investigate ways the SARS-CoV-2 coronavirus can be defeated using the body’s own defenses in conjunction with medical treatments and a possible vaccine. Now, researchers at the Boston University School of Medicine have...

Johnson & Johnson Investing to Learn How to Predict or Prevent Disease; Studies Could Lead to Clinical Laboratory Tests that Detect Disease Earlier and More Accurately

May 20, 2016 | Instruments & Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing

COPD and gestational diabetes research are the subject of two new projects aimed at intercepting diseases prior to onset and identifying preventive treatments Can new insights into the human genome make it possible to diagnose disease much earlier—even before symptoms can be observed? Multiple research programs are targeting this possibility. One example is being conducted by Johnson & Johnson (J&J). The American multinational medical-device company wants to leverage recent...

New Problem for Pathologists and Physicians: Should Patients Be Told about Incidental Findings from Clinical Laboratory Tests?

Jun 8, 2012 | Compliance, Legal, and Malpractice, Digital Pathology, Laboratory Management and Operations, Laboratory News, Laboratory Pathology

Pathologists and clinical laboratory managers will need a strategy for handling incidental findings When a genetic test for a certain type of cancer provides additional information that could affect the patient’s health, what is the ethical course of action for pathologists and clinical laboratory scientists? Should this information be disclosed to the physician who ordered that cancer test? In turn, should that physician inform his or her patient about these “incidental findings?” All medical...
;